2011 JMML Symposium
Thursday, December 8, 2011 from 12:00-6:00 PM, to Friday, December 9, 2011 from 8:00AM-12:00 PM
Embassy Suites San Diego Bay - Downtown, 601 Pacific Highway, San Diego, California, United States 92101. Tel: 619-239-2400. Fax: 619-239-1520.
The 2011 JMML International Symposium brings together clinical and laboratory researchers from around the world to advance the study of and collaboratively speed the cure of Juvenile Myelomonocytic Leukemia (JMML). This year's keynote speaker will be Dr. Frank McCormick, a RAS Pathway expert, Director of the UCSF Helen Diller Family Comprehensive Cancer Center, Associate Dean of the UCSF School of Medicine, and among the 25 most-cited scientists of the 1990s.
The 2011 JMML International Symposium will be held in conjunction with the American Society of Hematology (ASH) meeting in San Diego, California, on December 8th and 9th, 2011.
All physicians, clinical and laboratory medical researchers, and young investigators with an interest in JMML are welcome and encouraged to register for this scientific conference. Due to resource restrictions, we will not be able to coordinate a JMML family-oriented meeting this year but may in the future.
Click here to view the agenda (version 4 Nov 2011)
Dr. Bharat Agarwal, B. J. Wadia Hospital for Children, Mumbai, India
Dr. Phil Ancliff, Great Ormond Street Hospital, United Kingdom
Dr. Hamid Band, University of Nebraska Medical Center
Dr. Ben Braun, University of California, San Francisco
Dr. Silvia Bresolin, University of Padova, Italy
Dr. Cláudio Galvão de Castro Jr., Hospital de Clinicas de Porto Alegre, Brazil
Dr. Helene Cave, AP-HP Hôpital Robert Debré, Paris, France
Dr. Rebecca Chan, Indiana University School of Medicine
Dr. John Cunningham, University of Chicago
Dr. Andrica de Vries, Erasmus University, Rotterdam, The Netherlands
Dr. Stephan Grupp, University of Pennsylvania School of Medicine
Dr. Asahito Hama, Nagoya University, Nagoya, Japan
Dr. Kenichi Koike, Shinshu University School of Medicine, Matsumoto, Japan
Dr. Seiji Kojima, Nagoya University, Nagoya, Japan
Dr. Jennifer Lauchle, Genentech
Dr. Kenneth Lieuw, Uniformed Services University of the Health Sciences
Dr. Mignon Loh, University of California, San Francisco
Dr. Atsushi Manabe, St. Luke's International Hospital, Tokyo, Japan
Dr. Frank McCormick, University of California, San Francisco
Dr. Hideki Muramatsu, Nagoya University, Nagoya, Japan
Dr. Charlotte Niemeyer, University of Freiburg, Germany
Dr. Joao Bosco Oliveira, National Institutes of Health Clinical Center
Dr. Cheng-Kui Qu, Case Western Reserve University
Dr. Akira Shimada, Nagoya University, Nagoya, Japan
Dr. Malcolm Smith, National Cancer Institute
Dr. Marry Van Den Heuvel, Erasmus University, Rotterdam, The Netherlands
Standard registration price: $125 per person
THURSDAY NIGHT DINNER
We made a reservation at Re Do Gado, a wonderful Brazilian Steakhouse in walking distance from the conference, for Thursday evening at 6:30 pm (http://www.reidogado.net/). In addition to serving a wide variety of grilled meats, the restaurant also boasts a very large and diverse buffet of vegetarian dishes. Dinner will be pay-as-you-go, and the cost will be $50/person. Please let us know as you register if you would like to attend this dinner, as our Thursday night event has been well-attended in past years and has been a great way for conference attendees to socialize during the conference.
MISSION & GOALS OF THE JMML INTERNATIONAL SYMPOSIA AND WORKING GROUP MEETINGS
The mission of the annual JMML International Symposia and Working Group Meetings is to establish an interna tional scientific forum, driven simply by a focus on the JMML disease and not by country or institutional goals, that combines clinical, basic, and translational research in order to improve survivability among JMML patients.
The goals of this timely conference were four-fold:
- To share the latest developments in JMML laboratory and clinical research to strengthen and perpetuate international collaboration among investigators in the field;
- To provide a venue to coordinate standardized measurements for patients with JMML enrolled on international clinical trials;
- To engage new investigators in JMML research by encouraging attendance by junior scientists, under-represented minority investigators, and researchers with overlapping interests;
- To facilitate communication between JMML investigators and patient advocates to encourage the participation of JMML patients in ongoing basic and clinical research studies.
This conference was made possible in part through grants from the National Cancer Institute (NCI) and the Leukemia Lymphoma Society. Due to funding restrictions, travel reimbursements will be made on a first-come, first-served basis pending availability of funds and will be limited to (1) airfare only for speakers not otherwise attending the ASH annual meeting, and (2) one night of hotel room for speakers upon request only.